Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C BURNETT

Showing results (621-630 of 921) with videos related to

Pageof 93
Sort By:
Plants (Basel, Switzerland)|July 8, 2020
Identification of Quantitative Trait Loci Relating to Flowering Time, Flag Leaf and Awn Characteristics in a Novel <i>Triticum dicoccum</i> Mapping PopulationTally I C Wright, Angela C Burnett, Howard Griffiths, et al.
Hypertension (Dallas, Tex. : 1979)|March 12, 1998
Chronic oral endothelin type A receptor antagonism in experimental heart failureD D Borgeson, J A Grantham, E E Williamson, et al.
American Journal of Industrial Medicine|July 1, 1995
Assessment of mortality in the construction industry in the United States, 1984-1986C Robinson, F Stern, W Halperin, et al.
Genes, Chromosomes & Cancer|May 1, 1993
Molecular analysis of a t(11;14)(q23;q11) from a patient with null-cell acute lymphoblastic leukemiaR C Burnett, R Espinosa, T B Shows, et al.
Acta Crystallographica. Section D, Biological Crystallography|March 27, 2002
X-ray crystallographic analyses of symmetrical allosteric effectors of hemoglobin: compounds designed to link primary and secondary binding sitesMartin K Safo, Telih Boyiri, James C Burnett, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 25, 2016
Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actionsCandace Y W Lee, Brenda K Huntley, Daniel J McCormick, et al.
Circulation. Heart Failure|May 23, 2013
Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failureThomas G von Lueder, S Jeson Sangaralingham, Bing H Wang, et al.
Hypertension (Dallas, Tex. : 1979)|December 1, 1996
Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophyK Yamamoto, J C Burnett, M Jougasaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2024
Extended time, elevated expectations: The unappreciated downsides of pausing the tenure clockMaria A Holland, Katharina Maisel, Carolyn B Ibberson, et al.
Organic & Biomolecular Chemistry|February 13, 2019
In-flow photooxygenation of aminothienopyridinones generates iminopyridinedione PTP4A3 phosphatase inhibitorsNikhil R Tasker, Ettore J Rastelli, Isabella K Blanco, et al.
Pageof 93

Showing results (621-630 of 921) with videos related to

Sort By:
Pageof 93
Plants (Basel, Switzerland)|July 8, 2020
Identification of Quantitative Trait Loci Relating to Flowering Time, Flag Leaf and Awn Characteristics in a Novel <i>Triticum dicoccum</i> Mapping PopulationTally I C Wright, Angela C Burnett, Howard Griffiths, et al.
Hypertension (Dallas, Tex. : 1979)|March 12, 1998
Chronic oral endothelin type A receptor antagonism in experimental heart failureD D Borgeson, J A Grantham, E E Williamson, et al.
American Journal of Industrial Medicine|July 1, 1995
Assessment of mortality in the construction industry in the United States, 1984-1986C Robinson, F Stern, W Halperin, et al.
Genes, Chromosomes & Cancer|May 1, 1993
Molecular analysis of a t(11;14)(q23;q11) from a patient with null-cell acute lymphoblastic leukemiaR C Burnett, R Espinosa, T B Shows, et al.
Acta Crystallographica. Section D, Biological Crystallography|March 27, 2002
X-ray crystallographic analyses of symmetrical allosteric effectors of hemoglobin: compounds designed to link primary and secondary binding sitesMartin K Safo, Telih Boyiri, James C Burnett, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 25, 2016
Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actionsCandace Y W Lee, Brenda K Huntley, Daniel J McCormick, et al.
Circulation. Heart Failure|May 23, 2013
Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failureThomas G von Lueder, S Jeson Sangaralingham, Bing H Wang, et al.
Hypertension (Dallas, Tex. : 1979)|December 1, 1996
Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophyK Yamamoto, J C Burnett, M Jougasaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2024
Extended time, elevated expectations: The unappreciated downsides of pausing the tenure clockMaria A Holland, Katharina Maisel, Carolyn B Ibberson, et al.
Organic & Biomolecular Chemistry|February 13, 2019
In-flow photooxygenation of aminothienopyridinones generates iminopyridinedione PTP4A3 phosphatase inhibitorsNikhil R Tasker, Ettore J Rastelli, Isabella K Blanco, et al.
Pageof 93